CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $120,000 | -18.9% | 34,117 | -7.8% | 0.00% | – |
| Q3 2020 | $148,000 | +39.6% | 37,014 | -5.5% | 0.00% | – |
| Q2 2020 | $106,000 | +68.3% | 39,171 | +29.6% | 0.00% | – |
| Q1 2020 | $63,000 | +293.8% | 30,220 | +1914.7% | 0.00% | – |
| Q4 2017 | $16,000 | -84.3% | 1,500 | -76.6% | 0.00% | – |
| Q3 2017 | $102,000 | -8.9% | 6,404 | -31.0% | 0.00% | – |
| Q2 2017 | $112,000 | -24.8% | 9,286 | +29.3% | 0.00% | – |
| Q1 2017 | $149,000 | -62.9% | 7,181 | -72.8% | 0.00% | -100.0% |
| Q4 2016 | $402,000 | – | 26,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
| CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
| Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
| Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
| BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
| Artal Group S.A. | 500,000 | $425 | 0.02% |
| Hikari Power Ltd | 49,959 | $42 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |